AI interpretation based on checked source excerpts. Issuer assertions and evidence limitations remain explicit.
Policy quality-scores-2: six equally weighted categories. The overall score requires full coverage. Missing inputs are not zero. Qualitative grades are sourced interpretations, not probabilities. 5/6 · 18/10/2026
Moat50
Equal-weight average of four evidence-backed rubric grades (0–4), scaled to 100.
structural advantage · 2/4 · Equipment-specific compliance contracts and integrated instrument workflows support a current switching-cost advantage. Global specialist support strengthens delivery, but competitive superiority and switching expense are not quantified.
durability · 2/4 · Ongoing maintenance and compliance obligations support continuity across equipment use. Contract lengths, renewal outcomes and replacement friction are missing, while continued investment is explicitly required.
customer dependency · 2/4 · Specified-equipment services and plant integration create operational dependence. Service sales increased from $249.0 million to $274.3 million in second-quarter 2026, providing indirect continuity evidence rather than customer-level retention proof. Limited customization moderates dependence.
erosion resilience · 2/4 · Repeated favorable pricing and positive 2026 organic sales show resilience. Actual 2025 margin compression demonstrates incomplete insulation from costs, while distributor competition and price sensitivity limit protection. These results do not establish realized structural moat erosion.
Pricing power—
Insufficient evidence for every rubric criterion; no category score is inferred.
realized pricing · 3/4 · MD&A reports favorable realized pricing in 2023, 2024, 2025 and second-quarter 2026, establishing repeated observed pricing benefits rather than intentions alone. Magnitudes and price-related customer losses are not disclosed.
retention · 2/4 · Equipment-specific service contracts, growing reported service sales and positive organic sales provide indirect evidence of continuing demand. They cannot isolate renewals, repeat customers or the retention effect of price changes.
margin resilience · 2/4 · Pricing and productivity supported margins across several years, but did not fully offset tariffs, volume and mix pressures in 2025. Second-quarter 2026 improvement excluding one-time refunds also benefited from lower tariff costs, so it cannot be attributed solely to pricing power.
contractual freedom · — · Restrictions on retrospective variable pricing and discretion over product returns establish limited terms control, but do not establish freedom to reprice existing contracts, change service terms or terminate commitments.
Predictability94
Five consecutive annual periods. Equal weights: nondeclining revenue frequency; revenue-growth volatility (5–40pp); positive FCF frequency; FCF-margin volatility (3–20pp). Stability indicator, not a growth forecast.
- Nondeclining revenue years (%)
- 75.00
- Revenue growth volatility (pp)
- 3.33
- Positive FCF years (%)
- 100.00
- FCF margin volatility (pp)
- 1.36
Financial strength68
Equal-weight grades: debt/FCF (1–8x), net debt/earnings before interest and tax (0–5x), interest service (1–12x), current ratio (0.75–2x). Earnings use reported operating income, or reported pretax profit plus reported interest expense when operating income is unavailable. Interest service uses earnings/interest expense; if unavailable, it uses reported operating cash flow/cash interest paid, without relabeling cash paid as accrued expense. Nonpositive cash flow/earnings score 0 for their service component; reported zero interest with a positive numerator scores 100. Net cash scores 100 for net leverage. Missing disclosures remain unavailable. General nonfinancial-company rubric, not a credit rating; exceptional and nonoperating gains are not normalized out. IFRS finance-cost and cash-flow classifications retain their reported scope.
- debtFcfGrade
- 78.06
- netDebtEbitGrade
- 62.68
- interestCoverageGrade
- 100.00
- currentRatioGrade
- 30.99
- Debt / FCF (x)
- 2.54
- Net debt / operating income (x)
- 1.87
- Current ratio (x)
- 1.14
Capital allocation100
Three-year equal-weight indicators: pretax return on average invested capital (0–25%; equity + debt − cash, each year and its prior year), share-count growth (0–5%, lower better), share-based cost/revenue (2–20%, lower better), consolidated FCF/net income (0–1x). Return uses reported operating income or, if unavailable, EBIT calculated from reported pretax profit plus reported interest expense; exceptional/nonoperating gains are not normalized out. Share-based cost uses the reported cash-flow add-back or, if absent, separately reported recognized compensation expense; the latter never becomes an FCF adjustment. Nonpositive net income scores 0 for cash conversion; absent income/FCF stays unavailable. Nonpositive invested capital has no defined return and remains unavailable. Does not establish acquisition quality or buyback timing.
- 3-year pre-tax operating return (%)
- 57.67
- 3-year average dilution (%)
- -2.87
- 3-year average SBC / revenue (%)
- 0.52
- cashConversionGrade
- 100.00
Management63
Equal-weight average of four evidence-backed rubric grades (0–4), scaled to 100.
capital discipline · 2/4 · Operating cash generation remained around $956–968 million during 2023–2025 with capital spending around $104–107 million. First-half 2026 repurchases of $412.5 million exceeded operating cash after capital expenditures, alongside substantial debt and a small cash balance. Reported cash generation included a one-time tariff refund benefit. This supports mixed discipline; buyback value creation and acquisition returns are unproven.
incentive alignment · 3/4 · Actual 2025 equity awards combined performance units, options and restricted units. Very low realized performance-unit vesting demonstrates that performance conditions constrained payouts, while hedging restrictions and clawback provisions support alignment. The discretionary tariff adjustment weakens strict target discipline; ownership balances are missing.
execution · 2/4 · Service growth, positive 2026 organic sales and sustained cash generation support execution through indirect operating evidence. Actual 2025 sales, adjusted EPS and incentive-defined cash flow fell below targets, and gross margins faced realized pressure. The evidence establishes competent but uneven execution.
governance · 3/4 · An independent chair, annual director terms, executive exclusion from their own pay decisions and mandatory clawback provisions establish substantive governance safeguards. Management reported effective financial controls. These disclosures support strong structures, while long-term oversight effectiveness and the anticipated board election outcome remain unproven.
Evidence
These contracts represent an obligation to perform repair and other services including regulatory compliance qualification, calibration, certification, and preventative maintenance on a customer’s pre-defined equipment over the contract period.
Revenue recognition — equipment-specific service contract obligations · Filed 31/07/2026
LabX, our laboratory software platform, manages and analyzes data generated by our balances, titrators, pH meters, physical value analyzers, and other analytical instruments like UV/VIS spectrophotometers.
Business — LabX instrument data management · Filed 06/02/2026
Our instruments offer leading multi-parameter capabilities and plant-wide control system integration, which are key for integrated measurement of multiple parameters to secure production quality and efficiency.
Business — process analytics and plant control integration · Filed 06/02/2026
With a worldwide network of specialists, we support customers in critical process applications, compliance, and systems integration questions.
Business — worldwide specialist support · Filed 06/02/2026
Our products are sold in more than 140 countries and we have a direct presence in approximately 40 countries.
Business — geographic sales and direct presence · Filed 06/02/2026
INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME Three months ended June 30, 2026 and 2025 (In thousands, except share data) (unaudited) June 30, 2026 June 30, 2025 Net sales Products $ 753,003 $ 734,244 Service 274,311 248,977 Total net sales 1,027,314 983,221 Cost of sales Products 253,275 289,314 Service 123,821 114,031 Gross profit 650,218 579,876 Research and development 52,989 49,285 Selling, general and administrative 263,334 247,298 Amortization 19,426 17,581 Interest expense 17,246 16,779 Restructuring charges 5,450 3,557 Other charges (income), net 2,372 (3,281) Earnings before taxes 289,401 248,657 Provision for taxes 56,502 46,309 Net earnings $ 232,899 $ 202,348 Basic earnings per common share: Net earnings $ 11.57 $ 9.78 Weighted average number of common shares 20,121,564 20,687,312 Diluted earnings per common share: Net earnings $ 11.55 $ 9.76 Weighted average number of common and common equivalent shares 20,166,298 20,738,699 Comprehensive income, net of tax (Note 9) $ 256,841 $ 131,806 The accompanying notes are an integral part of these interim consolidated financial statements.
Unaudited consolidated statements — second-quarter product and service sales and earnings · Filed 31/07/2026
The Company’s products typically require no significant production, modification, or customization of the hardware or software that is essential to the functionality of the products.
Revenue recognition — limited product customization · Filed 31/07/2026
Competition in the U.S. laboratory market is also influenced by the presence of large distributors that sell not only our products but those of our competitors as well.
Competition — distributors selling competing products · Filed 06/02/2026
demand for less sophisticated products, price is a more important factor than in developed markets.
Competition — emerging-market price sensitivity · Filed 06/02/2026
To remain competitive, we must continue to invest in research and development, sales and marketing, customer service and support, and operational excellence throughout our supply chain.
Competition — continuing investment requirements · Filed 06/02/2026
The gross profit as a percentage of net sales for 2023 primarily reflects favorable price realization that benefits from our innovative product portfolio, and results from our cost savings initiatives, partially offset by lower sales volume, unfavorable mix, and foreign currency.
MD&A — 2023 realized pricing and gross profit drivers · Filed 09/02/2024
The decrease in gross profit as a percentage of net sales for 2025 primarily reflects increased tariff costs, lower sales volume related to the recovery of shipping delays in the prior year, and unfavorable business mix, partially offset by favorable price realization and benefits from our SternDrive program.
MD&A — 2025 gross margin decline and favorable price realization · Filed 06/02/2026
The gross profit as a percentage of net sales for 2024 primarily reflects favorable price realization that benefits from our innovative product portfolio, benefits from our productivity, and cost savings initiatives and business mix, offset in part by investments in our service organization.
MD&A — 2024 realized pricing and gross profit drivers · Filed 07/02/2025
government and customer refunds, the increase in gross profit as a percentage of net sales for the three months ended June 30, 2026 primarily reflects favorable price realization, lower tariff costs, and benefits from our SternDrive program, partially offset by unfavorable foreign currency and higher transportation costs.
MD&A — second-quarter 2026 gross margin drivers excluding one-time refunds · Filed 31/07/2026
Organic local currency net sales, which exclude acquisitions and the one-time tariff-related customer refunds, increased 4% for the three months and 3% for the six months ended June 30, 2026, respectively.
MD&A — organic local currency sales growth excluding acquisitions and customer refunds · Filed 31/07/2026
INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS Six months ended June 30, 2026 and 2025 (In thousands) (unaudited) June 30, 2026 June 30, 2025 Cash flows from operating activities: Net earnings $ 402,353 $ 365,935 Adjustments to reconcile net earnings to net cash provided by operating activities: Depreciation 26,460 25,334 Amortization 39,038 34,774 Deferred tax benefit (177) (2,840) Share-based compensation 10,840 10,521 Proceeds from government grant 6,240 — Increase (decrease) in cash resulting from changes in: Trade accounts receivable, net 40,024 39,216 Inventories (27,965) (18,062) Other current assets (19,338) (2,326) Trade accounts payable (37,417) (8,675) Taxes payable (11,106) 22,241 Accruals and other 21,258 (35,303) Net cash provided by operating activities 450,210 430,815 Cash flows from investing activities: Purchase of property, plant and equipment (45,206) (41,132) Acquisitions (2,242) (2,915) Other investing activities 14,158 (10,510) Net cash used in investing activities (33,290) (54,557) Cash flows from financing activities: Proceeds from borrowings 955,995 1,122,578 Repayments of borrowings (966,911) (1,063,372) Proceeds from stock option exercises 1,415 9,062 Repurchases of common stock (412,500) (437,497) Payments of excise tax on repurchases of common stock (7,555) — Acquisition contingent consideration payment (2,476) — Other financing activities (50) (920) Net cash used in financing activities (432,082) (370,149) Effect of exchange rate changes on cash and cash equivalents (343) (3,646) Net increase (decrease) in cash and cash equivalents (15,505) 2,463 Cash and cash equivalents: Beginning of period 66,888 59,362 End of period $ 51,383 $ 61,825 The accompanying notes are an integral part of these interim consolidated financial statements.
Unaudited cash flow statement — operating cash, investment, borrowing and repurchases · Filed 31/07/2026
Cash provided by operating activities totaled $955.8 million in 2025, compared to $968.3 million in 2024 and $965.9 million in 2023.
Liquidity — operating cash generation, 2023–2025 · Filed 06/02/2026
Our capital expenditures totaled $107.1 million in 2025, $103.9 million in 2024, and $105.3 million in 2023.
Liquidity — capital expenditures, 2023–2025 · Filed 06/02/2026
Cash provided by operating activities totaled $450.2 million during the six months ended June 30, 2026, compared to $430.8 million in the corresponding period in 2025 and includes a benefit of $42.9 million related to one-time tariff related U.S.
Liquidity — operating cash flow and one-time tariff refund benefit · Filed 31/07/2026
INTERIM CONSOLIDATED BALANCE SHEETS As of June 30, 2026 and December 31, 2025 (In thousands, except share data) (unaudited) June 30, 2026 December 31, 2025 ASSETS Current assets: Cash and cash equivalents $ 51,383 $ 66,888 Trade accounts receivable, less allowances of $17,706 at June 30, 2026 and $16,857 at December 31, 2025 731,480 778,243 Inventories 411,563 387,228 Other current assets and prepaid expenses 152,961 130,308 Total current assets 1,347,387 1,362,667 Property, plant and equipment, net 831,941 845,636 Goodwill 735,214 739,225 Other intangible assets, net 266,258 278,910 Deferred tax assets, net 41,268 41,380 Other non-current assets 448,876 444,828 Total assets $ 3,670,944 $ 3,712,646 LIABILITIES AND SHAREHOLDERS’ EQUITY Current liabilities: Trade accounts payable $ 229,801 $ 266,628 Accrued and other liabilities 285,517 237,482 Accrued compensation and related items 171,919 199,516 Deferred revenue and customer prepayments 257,482 229,378 Taxes payable 188,492 201,181 Short-term borrowings and current maturities of long-term debt 67,290 63,931 Total current liabilities 1,200,501 1,198,116 Long-term debt 2,044,673 2,088,241 Deferred tax liabilities, net 145,514 151,784 Other non-current liabilities 267,433 298,141 Total liabilities 3,658,121 3,736,282 Commitments and contingencies (Note 14) Shareholders’ equity: Preferred stock, $0.01 par value per share; authorized 10,000,000 shares — — Common stock, $0.01 par value per share; authorized 125,000,000 shares; issued 44,786,011 and 44,786,011 shares; outstanding 20,036,559 shares and 20,359,353 shares at June 30, 2026 and December 31, 2025, respectively 448 448 Additional paid-in capital 947,927 936,276 Treasury stock at cost (24,749,452 shares at June 30, 2026 and 24,426,658 shares at December 31, 2025) (10,255,168) (9,839,399) Retained earnings 9,640,316 9,238,196 Accumulated other comprehensive loss (320,700) (359,157) Total shareholders' equity 12,823 (23,636) Total liabilities and shareholders’ equity $ 3,670,944 $ 3,712,646 The accompanying notes are an integral part of these interim consolidated financial statements.
Unaudited balance sheet — cash, debt and equity · Filed 31/07/2026
As part of the bifurcation, the Compensation Committee structured the composition of each grant in this manner: 1/3 performance share units, 1/3 non-qualified stock options, and 1/3 restricted stock units.
Compensation discussion — composition of actual 2025 equity grants · Filed 18/03/2026
Over the past three years, based on the performance of the company pursuant to the criteria outlined above, the performance share units, including the off-cycle grant to the CEO in April 2021, have vested as follows: Grant Performance Period End Shares Earned as % of Target November 2020 November 2023 4.7% April 2021 April 2024 0.0% November 2021 November 2024 0.0% November 2022 November 2025 0.3% In 2025, named executive officers also received restricted stock unit grants.
Compensation discussion — actual performance share vesting outcomes · Filed 18/03/2026
In addition, the Compensation Committee approved a one-time, modest adjustment, applicable to all employees who participate in the company’s POBS annual cash incentive plans, to partially offset the impact of international trade disputes.
Compensation discussion — approved adjustment to annual incentive performance · Filed 18/03/2026
The board and the company’s executive officers, and their designees, are prohibited from any transaction hedging the ownership of company securities, including trading in publicly-traded options, puts, calls, or other derivative instruments that are directly related to company securities, and are also generally restricted from transactions pledging ownership of company securities.
Governance — executive and director hedging and pledging restrictions · Filed 18/03/2026
2025 Threshold, Target, Maximum, and Actual Performance 2025 Performance Targets Threshold Target Maximum Actual Adjusted Non-GAAP Earnings Per Share(1) $42.29 $43.62 $47.61 $42.89 Net Cash Flow(2) $1,005.8 million $1,060.2 million $1,223.4 million $1,042.1 million Group Sales (at budgeted currency rates) $3,814.3 million $3,892.9 million $4,128.7 million $3,885.5 million (1)Excludes purchased intangible amortization (net of tax) of $21.1 million, restructuring charges (net of tax) of $14.5 million and a net benefit (net of tax) of $3.6 million related to contingent consideration associated with previous acquisitions less acquisition transaction costs (net of tax) of $1.7 million.
Compensation discussion — 2025 targets and actual operating performance · Filed 18/03/2026
Though the Board Chair is independent, the board also has established a lead director (the Lead Director) who assists the Board Chair as needed and oversees all meetings of directors at which the Board Chair is not present.
Board leadership — independent chair and lead director · Filed 18/03/2026
Each director holds a one-year term until the next annual meeting of shareholders.
Board structure — annual director terms · Filed 18/03/2026
No executive officer plays a role in making compensation decisions with respect to his or her own compensation.
Compensation governance — executives excluded from their own compensation decisions · Filed 18/03/2026
In the event the company is required to prepare an accounting restatement of its financial statements due to the material noncompliance of the company with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period, the board shall require reimbursement or forfeiture of any excess incentive-based compensation received by any applicable employee during the three (3) completed fiscal years immediately preceding the date on which the company is required to prepare an accounting restatement.
Governance — mandatory compensation recovery policy · Filed 18/03/2026
Based on our assessment, we concluded that, as of December 31, 2025, the Company’s internal control over financial reporting is effective.
Controls — management conclusion on effective financial reporting controls · Filed 06/02/2026
Contracts do not contain variable pricing arrangements that are retrospective, except for rebate programs.
Revenue recognition — retrospective pricing restrictions and rebate exception · Filed 31/07/2026
The Company generally maintains the right to accept or reject a product return in its terms and conditions and also maintains appropriate accruals for outstanding credits.
Revenue recognition — contractual product return discretion · Filed 31/07/2026
